Author
Aziz Karaoğlu
Also Known As
A Karaoglu, A. Karaoglu, A. Karaoğlu, A. O. Karaoglu, Ahmet Ensar Karaoğlu, Aziz KARAOGLU, Aziz KARAOĞLU, Aziz Karaoglu, Aziz Karaoğlu, C. Ramesh
108
Publications
1.8K
Citations
14
H-Index
33
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 11 | 12 | 1.4K |
2 | Health Sciences | 2 | 2 | 889 |
3 | Endocrinology | 2 | 2 | 69 |
4 | Biochemistry | 1 | 1 | 11 |
5 | Nephrology | 1 | 1 | 40 |
Aziz Karaoğlu
×
18
Publications
1.6K
Citations
14
H-Index
| Year | Citations | |
|---|---|---|
2023 | 521 | |
2003 | 368 | |
2005 | 302 | |
2007 | 120 | |
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park, Metastatic Urothelial CancerUrologyGenitourinary CancerSelect Fgfr AlterationsMedicine | 2023 | 69 |
2008 | 40 | |
2008 | 29 | |
2020 | 29 | |
2015 | 22 | |
2010 | 21 |
Page 1
Page 1